Bevacizumab in Multiple Phase I Combinations
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib in Resected Non-small Cell Lung Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib in Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1 Study With Sorafenib and Sirolimus
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib With TACE to Treat Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE3
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib
- Status
- COMPLETED
- Phase
- PHASE3